Back to Search Start Over

Genentech's cancer restructure was made 'for scientific reasons': exec.

Genentech's cancer restructure was made 'for scientific reasons': exec.

Authors :
Waldron, James
Source :
FierceBiotech; 9/10/2024, pN.PAG-N.PAG, 1p
Publication Year :
2024

Abstract

The recent decision to merge Genentech's two cancer departments was made for "scientific reasons," according to executives. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
LAYOFFS
ONCOLOGY

Details

Language :
English
Database :
Complementary Index
Journal :
FierceBiotech
Publication Type :
Periodical
Accession number :
179620139